Skip to main content

Year: 2021

Strategy Announcement – Central Government Borrowing Strategy 2022

Central government borrowing strategy 2022 Target for bond issuance at kr. 65 billionThe target for sales of domestic government bonds is kr. 65 billion. Opening of the first green bondThe list of on-the-run issues is expanded with a green 10-year nominal government bond. In addition, a new inflation-linked bond will be opened. Target at kr. 35 billion for the short-term loan programmesThe T-bill programme is adjusted such that a new 6-month T-bill will be opened every third month. Going forward, the programme will consist of two issues. The commercial paper programmes are kept active. The strategy announcement is available on www.governmentdebt.dk. Enquiries can be directed to Martin Wagner Toftdahl on tel. +45 3363 6661 or mail: governmentdebt@nationalbanken.dk.AttachmentANALYSE_No 31_Central government borrowing strategy...

Continue reading

The Scotts Miracle-Gro Company Announces Commencement of Exchange Offer for 4.375% Senior Notes due 2032

MARYSVILLE, Ohio, Dec. 22, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) today announced that it has commenced a registered exchange offer to exchange any and all of its $400,000,000 aggregate principal amount of 4.375% Senior Notes due 2032 which were issued in a private placement on August 13, 2021 (the “Original Notes”) for an equal principal amount of its 4.375% Senior Notes due 2032 which have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”). The exchange offer is being made to satisfy the Company’s obligations under a registration rights agreement entered into on August 13, 2021 in connection with the issuance of the Original Notes, and does not represent a new financing transaction. The Company will not receive any further proceeds from the exchange offer. The terms...

Continue reading

Milestone Scientific Announces Purchase Agreement for its CompuFlo® Epidural / CathCheck™ Verification System Disposables with a Premier Northeast Teaching Hospital

ROSELAND, N,J., Dec. 22, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today reported, that following a successful trial, it has signed an agreement for the purchase of its CompuFlo® Epidural and CathCheck™ Verification System disposables with a major Northeast teaching hospital, which is part of one of the leading health systems in the United States. “We are honored to announce adoption of our CompuFlo Epidural and CathCheck Verification System by yet another important and prestigious hospital,” said Arjan Haverhals, CEO of Milestone Scientific. “This approval follows an extensive trial, which further validates the safety and efficacy of our technology. As a teaching hospital, our tools provide residents,...

Continue reading

TFI International Publishes Inaugural ESG Report

MONTREAL, Dec. 22, 2021 (GLOBE NEWSWIRE) — TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, today announced the release of its inaugural Environmental, Social and Governance (“ESG”) Report. The report, prepared by TFI International’s leadership team with oversight by its Board of Directors, details TFI International’s priorities and initiatives related to environmental stewardship, social commitments, corporate governance and community service. “Our inaugural ESG Report is a testament to our decades-long commitment to conducting business in a first-class way, with unwavering dedication to our people, our customers, and the communities we serve,” stated Alain Bédard, Chairman, President and Chief Executive Officer of TFI International. “Over the years, we have fostered...

Continue reading

AmeriCann’s Massachusetts Cannabis Center Featured on CNN Special Report

Dr. Sanjay Gupta’s Award-winning Series WEED 6: Marijuana and Autism Will Broadcast Again on Friday, Dec. 24 at 6 P.M. EST BOSTON, Dec. 22, 2021 (GLOBE NEWSWIRE) — via InvestorWire — AmeriCann Inc. (OTCQB:ACAN) (the “Company”), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, announced that the Company’s Massachusetts Cannabis Center was featured on the award-winning series by Dr. Sanjay Gupta on CNN exploring cannabis treatments for autism. “For nearly a decade Dr. Sanjay Gupta’s breakthrough series has shattered myths and introduced the healing properties of cannabis on a global stage,” stated AmeriCann CEO Tim Keogh. “We are proud to play a role in helping Dr. Gupta present the considerable benefits that severe autism patients have achieved being treated...

Continue reading

The Scotts Miracle-Gro Company Announces Commencement of Exchange Offer for 4.000% Senior Notes due 2031

MARYSVILLE, Ohio, Dec. 22, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) today announced that it has commenced a registered exchange offer to exchange any and all of its $500,000,000 aggregate principal amount of 4.000% Senior Notes due 2031 which were issued in a private placement on March 17, 2021 (the “Original Notes”) for an equal principal amount of its 4.000% Senior Notes due 2031 which have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”). The exchange offer is being made to satisfy the Company’s obligations under a registration rights agreement entered into on March 17, 2021 in connection with the issuance of the Original Notes, and does not represent a new financing transaction. The Company will not receive any further proceeds from the exchange offer. The terms of...

Continue reading

BetterLife’s Wholly-Owned Subsidiary, Altum Pharmaceuticals, Obtains Non-Dilutive Financing Commitment From Strategic Investor!

VANCOUVER, British Columbia, Dec. 22, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU) today announced that its wholly-owned subsidiary, Altum Pharmaceuticals Inc. (“Altum”), has signed an agreement with an European-based investor group to complete a non-brokered financing of up to US$5.0 million by way of private placement of Altum’s common shares. The financing will be in tranches and will commence January of 2022. At the completion of the US$5.0 million financing, the investor group will own approximately 12.5% of Altum’s issued and outstanding shares. “Our team is working diligently to advance the pre-clinical and clinical programs of Altum that are of extreme importance in providing potential treatment for COVID-19 and its variants. This funding will provide...

Continue reading

Canoe Announces Changes to its Board of Directors and Management

TORONTO, Dec. 22, 2021 (GLOBE NEWSWIRE) — Canoe Mining Ventures Corp. (TSXV:CLV) (“Canoe” or the “Company”) announces the resignations and retirements of co-founder Duane Parnham and Dr. Roger Laine from its board of directors (the “Board”). Mr. Parnham has retired as Director, President and CEO of Canoe and Dr. Laine has retired as an independent director, effective December 21, 2021. Director and co-founder Scott Kelly has been appointed to succeed Mr. Parnham as Chief Executive Officer. The Board thanks Mr. Parnham and Dr. Laine for their valuable contributions to Canoe and impact on the mining industry. “We appreciate the guidance and leadership Mr. Parnham has provided the Company since its inception and celebrate his thirty plus year career as a geological and environmental consultant, dealmaker, philanthropist,...

Continue reading

Kvika banki hf.: Kvika establishes EMTN programme for notes to be listed In Ireland

Kvika’s base prospectus for the issue of foreign currency notes, to be listed on the Euronext Stock Exchange in Dublin Ireland, has been approved by relevant authorities. This is a Euro Medium Term Note programme that allows Kvika to issue notes in the equivalent amount of up to EUR 500 million in various currencies and at fixed or floating rates. Marinó Örn Tryggvason, CEO: “Access to foreign funding sources is an important factor in the growth and development of Kvika, creating opportunities for diversification of funding risk and pursuit of funding in new markets. A key prerequisite for such access are solid operations and a sound balance sheet, where Kvika’s profitable operations and increased financial strength following the merger of Kvika, TM and Lykill earlier this year have further strengthened Kvika as an Issuer. By listing...

Continue reading

CSX Announces Date for Fourth Quarter Earnings Release and Earnings Call

JACKSONVILLE, Fla., Dec. 22, 2021 (GLOBE NEWSWIRE) — CSX Corp. (NASDAQ: CSX) will release fourth quarter financial and operating results after the market close on Thursday, January 20, 2022. This will be followed by a conference call and live webcast hosted by the company’s management team at 4:30 p.m. Eastern Time. Those interested in participating via teleconference may dial 1-888-510-2008. Callers outside the U.S. may dial 1-646-960-0306. Participants should dial in 10 minutes prior to the call and use 3368220 as the passcode. Presentation materials and access to the webcast will be available on the company’s website at http://investors.csx.com. Following the earnings call, a webcast replay will be archived on the company’s website. About CSX and its Disclosures CSX, based in Jacksonville, Florida, is a premier transportation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.